Error loading player: No playable sources found
PFF1
What’s New with the 340B Drug Discount Program: A Policy Update
Date
March 10, 2023
Explore related products in the following collection:
This session will provide a general update on the 340B Drug Pricing Program that includes the topics of litigation status, manufacturer restrictions, and any anticipated regulatory challenges related to the program. Given the program's current status, advocacy tools will be provided to help defend the program at the state and federal levels.
Learning Objectives
- Understand the relationship between financial stability of health centers and their ability to provide more effective, equitable care.
- Discuss how adoption of the Raising the Bar principles and action-steps can enhance existing health center goals and advance equity, inform strategic planning, and enhance population health.
- Describe recommendations to support health centers with value-based care and payment models that include reimbursement for addressing social needs, partnering with community, and investing in workforce development in CHCs.
Speakers
Elizabeth Linderbaum, MPP
Deputy Director, Regulatory Affairs, NACHC
Jason Reddish, JD
Partner, Feldesman Tucker Leifer Fidell LLP
Peggy Tighe, JD
Principal, Powers Pyles Sutter & Verville PC
